BioHarvest Science – Vinia
  • BioHarvest Sciences (BHSC) has announced the first multimedia campaign for VINIA in the USA, Phase 1
  • The company is scaling up its US marketing in line with a 2022 growth plan that aims for significant growth in sales orders following commercial entry in 2021
  • The initial phase will include TV and online advertising with a special focus on Christian programming, which includes TBN
  • BioHarvest Sciences is a Biotech firm which is the developer and owner of the proprietary and patent-protected bio-farming technology
  • BioHarvest Sciences Inc. (BHSC) is up 3.13 per cent, trading at C$0.33 per share at 12:58 pm ET

BioHarvest Sciences (BHSC) has announced the first multimedia campaign for VINIA in the USA, Phase 1.

The company is scaling up its US marketing in line with a 2022 growth plan. It aims for significant growth in sales orders following commercial entry in 2021.

The initial phase will include TV and online advertising focusing on Christian programming, which includes TBN. TBN (Trinity Broadcasting Network) is the world’s largest religious-based television network. As part of the sponsorship agreement with TBN, Sobel will appear on the network’s flagship shows hosted by Eric Metaxas and Mike Huckabee.

Ilan Sobel, the CEO of BioHarvest, commented on the news.

“We are delighted to launch our first integrated marketing campaign aimed at expanding our loyal customer base here in the USA. Bringing our new 20 Ton production facility online was integral to scaling global VINIA supply. This marketing launch is testament to the entire VINIA team’s coordinated dedication to making it happen.”

The company created the new 60-second VINIA commercial for the TBN campaign, starting Aug 15, 2022. The campaign underscores VINIA’s concept of “Cellular Nutrition” and the benefits of increased blood flow, bringing in Sobel and members of his own family.

BioHarvest Sciences is a Biotech firm which is the developer and owner of proprietary and patent-protected bio-farming technology. The technology can grow the active and beneficial ingredients in fruit and plants, at an industrial scale, without the need to grow the plant itself.

BioHarvest Sciences Inc. (BHSC) is up 3.13 per cent, trading at C$0.33 per share at 12:58 pm ET.


More From The Market Online

PharmAla Biotech launches educational portal for MDMA

PharmAla Biotech (CSE:MDMA) launches its Prescribers Portal for medical practitioners to learn more about MDMA.

Cancer-fighting pharma stock eyes 2027 regulatory approval

Theralase Technologies (TSXV:TLT), a cancer-fighting pharma stock, expands its team with two clinical research associates.

PharmaDrug-PharmaTher Holdings JV submits clinical, regulatory package

Sairiyo Therapeutics, a PharmaDrug (CSE:PHRX) and PharmaTher Holdings (CSE:PHRM) joint venture, pursues a human clinical study in Australia.